Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Frequently asked questions
What sector does Tandem Diabetes Care, Inc (TNDM) operate in?
Tandem Diabetes Care, Inc belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Tandem Diabetes Care, Inc (TNDM) current stock price?
As of the latest data, Tandem Diabetes Care, Inc stock price is $18.90, with a previous close of $17.43. Tandem Diabetes Care, Inc gained $1.47 in the last trading session, representing a 8.43% increase.
What is Tandem Diabetes Care, Inc (TNDM) current market capitalization?
Tandem Diabetes Care, Inc market cap is approximately 1.32 billion.
What is Tandem Diabetes Care, Inc (TNDM) Earnings Per Share (EPS)?
The trailing EPS is -$0.89, and the forward EPS is $0.16.
What is Tandem Diabetes Care, Inc (TNDM) EBITDA?
Tandem Diabetes Care, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -13.74 million.
Does Tandem Diabetes Care, Inc (TNDM) pay dividends?
No. Tandem Diabetes Care, Inc does not pay a dividend.
How did Tandem Diabetes Care, Inc (TNDM) perform in its most recent earnings report?
In the last report (June 30, 2026), Tandem Diabetes Care, Inc posted an EPS surprise of 8.82% and a revenue surprise of -0.2%.
When is Tandem Diabetes Care, Inc (TNDM) next earnings report?
Tandem Diabetes Care, Inc is expected to release its next earnings report on September 30, 2026.
What is Tandem Diabetes Care, Inc (TNDM) beta (volatility) score?
Tandem Diabetes Care, Inc has a beta of 1.662, suggesting it is more volatile than the market.